Related Experiment Videos
Abnormal glucocorticoid receptors in acute leukemia cells
Blood
|February 1, 1982
Summary
Abnormal glucocorticoid receptors in leukemia cells may prevent response to steroid therapy. Researchers identified distinct receptor binding patterns in leukemia, suggesting a mechanism for treatment resistance.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Glucocorticoid receptors (GRs) are critical for normal cellular function.
- DEAE chromatography and glycerol gradient centrifugation are standard methods for characterizing GRs.
- Altered GR characteristics are implicated in various diseases, including cancers.
Purpose of the Study:
- To investigate glucocorticoid receptor (GR) binding characteristics in acute leukemia.
- To determine if abnormalities in GRs correlate with treatment response.
Main Methods:
- Utilized 3H-triamcinolone acetonide (3H-TA) to label GRs.
- Employed DEAE chromatography and glycerol gradient centrifugation to analyze GRs.
- Assessed DNA-binding capacity of GRs in normal tissues and leukemia cells.
Main Results:
- Normal tissues exhibit two distinct GR components (Peak I and Peak II) with specific salt elution and sedimentation values.
- A significant proportion of acute leukemia cases (35/62) displayed abnormal GR binding patterns.
- Abnormal GRs often lacked DNA-binding capacity and exhibited altered sedimentation coefficients, suggesting functional deficits.
Conclusions:
- Abnormal glucocorticoid receptor characteristics are prevalent in acute leukemia.
- These molecular alterations may underlie resistance to glucocorticoid therapy in leukemia patients.
- Further research into GR function could identify novel therapeutic strategies.